deLeon, J, Diaz, F.
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res
2005; 76: 135–57.
Kelly, DL, McMahon, RP, Wehring, HJ, Liu, F, Mackowick, KM, Boggs, DL, et al.
Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull
2011; 37: 832–8.
Kao, Y-C, Liu, Y-P, Cheng, T-H, Chou, M-K.
Cigarette smoking in outpatients with chronic schizophrenia in Taiwan: relationships to socio-demographic and clinical characteristics. Psychiatr Res
2011; 190: 193–9.
Kotov, R, Guey, LT, Bromet, EJ, Schwartz, JE.
Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity. Schizophr Bull
2008; 36: 173–81.
Barnes, M, Lawford, B, Burton, S, Heslop, K, Noble, E, Hausdorf, K, et al.
Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use? Aust N Z J Psychiatry
2006; 6–7: 575–80.
Aguilar, MC, Gurpegui, M, Diaz, FJ, De Leon, J.
Nicotine dependence and symptoms in schizophrenia: Naturalistic study of complex interactions. Br J Psychiatry
2005; 186: 215–21.
Patkar, A, Gopalakrishnan, R, Lundy, A, Leone, F, Certa, K, Weinstein, S.
Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. J Nerv Ment Dis
2005; 190: 604–10.
Herran, A, deSantiago, A, Sandoya, M, Fernandez, M, Dez-Manrique, J, Vazquez-Barquero, J.
Determinants of smoking behaviour in outpatients with schizophrenia. Schizophr Res
2000; 41: 373–81.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
Telfer, S, Shivashankar, S, Krishnadas, R, McCreadie, RG, Kirkpatrick, B.
Tardive dyskinesia and deficit schizophrenia. Acta Psychiatr Scand
2011; 124: 357–62.
Kay, SR, Fiszbein, A, Opler, LA.
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull
1987; 13: 261–76.
de Leon, J, Diaz, FJ, Becona, E, Gurpegui, M, Jurado, D, Gonzalez-Pinto, A.
Exploring brief measures of nicotine dependence for epidemiological surveys. Addict Behav
2003; 28: 1481–6.
Fagerstrom, KO, Kunze, M, Schoberberger, R, Breslau, N, Hughes, JR, Hurt, RD, et al.
Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control
1996; 5: 52–6.
Lane, RD, Glazer, WM, Hansen, TE, Berman, WH, Kramer, SI.
Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale. J Nerv Ment Dis
1985; 173: 353–7.
A rating scale for drug-induced akathisia. Br J Psychiatry
1989; 154: 672–6.
Simpson, G, Angus, J.
A rating scale for extrapyramidal side effects. Acta Psychiatr Scand
1970; 212: 11–19.
Kirkpatrick, B, Buchanan, RW, Breier, A, Carpenter, WT. Jr
Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Res
1993; 47: 47–56.
Weissman, MM, Bothwell, S.
Assessment of social adjustment by patient self-report. Arch Gen Psychiatry
1976; 33: 1111–5.
World Health Organization. Guidelines for ATC Classification and DDD Assignment (13th edn). WHO Collaborating Centre for Drugs Statistics Methodology, 2009.
Palaniyappan, L, Liddle, PF.
Differential effects of surface area, gyrification and cortical thickness on voxel based morphometric deficits in schizophrenia. Neuroimage
2012; 60: 693–9.
Preacher, KJ, Hayes, AF.
Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods
2008; 40: 879–91.
Whyte, B, Gordon, D, Haw, S, Fischerbacher, C, Scott, N, Harrison, R.
An Atlas of Tobacco Smoking in Scotland: A Report Presenting Estimated Smoking Prevalence and Smoking Attributable Deaths within Scotland. NHS Health Scotland, 2007.
Kelly, C, McCreadie, R.
Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry
1999; 156: 1751–7.
Tandon, R, Nasrallah, HA, Keshavan, MS.
Schizophrenia, ‘just the facts’ 4. Clinical features and conceptualization. Schizophr Res
2009; 110: 1–23.
Myles, N, Newall, H, Compton, MT, Curtis, J, Nielssen, O, Large, M.
The age at onset of psychosis and tobacco use: a systematic meta-analysis. Soc Psychiatry Psychiatr Epidemiol
2011; Sep 8. Epub ahead of print.
Pierce, JP, Dwyer, T, DiGiusto, E, Carpenter, T, Hannam, C, Amin, A, et al.
Cotinine validation of self–reported smoking in commercially run community surveys. J Chronic Dis
1987; 40: 689–95.
Panday, S, Reddy, SP, Ruiter, RA, Bergstrom, E, de Vries, H.
Nicotine dependence and withdrawal symptoms among occasional smokers. J Adolesc Health
2007; 40: 144–50.
Levander, S, Eberhard, J, Lindstrom, E.
Nicotine use and its correlates in patients with psychosis. Acta Psychiatr Scand
2007; 116(S435): 27–32.
Weinberger, AH, Reutenauer, EL, Allen, TM, Termine, A, Vessicchio, JC, Sacco, KA, et al.
Reliability of the Fagerstrom Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia. Drug Alcohol Depend
2007; 86: 278–82.
Salokangas, R, Saarijarvi, S, Taiminen, T, Lehto, H, Niemi, H, Ahola, V, et al.
Effect of smoking on neuroleptics in schizophrenia. Schizophr Res
1997; 23: 55–60.
Yang, YK, Nelson, L, Kamaraju, L, Wilson, W, McEvoy, JP.
Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia. Neuropsychopharmacology
2002; 27: 684–6.
Zhang, XY, Yu, YQ, Sun, S, Zhang, X, Li, W, Xiu, MH, et al.
Smoking and tardive dyskinesia in male patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry
2011; 35: 1765–9.
Why do patients with schizophrenia smoke? Curr Opin Psychiatry
2010; 23: 112–9.
Matthews, A, Wilson, V, Mitchell, S.
The role of antipsychotics in smoking and smoking cessation. CNS Drugs
2011; 25: 299–315.
Kumari, V, Postma, P.
Nicotine use in schizophrenia: The self medication hypotheses. Neurosci Biobehav Rev
2005; 29: 1021–34.
Neurobiological links between nicotine addiction and schizophrenia. J Dual Diagn
2007; 3: 27–42.
Brody, A, Olmstead, R, London, E, Farahi, J, Meyer, J, Grossman, P, et al.
Smoking induced ventral striatum dopamine release. Am J Psychiatry
2004; 161: 1211–8.
Howes, OD, Kapur, S.
The dopamine hypothesis of schizophrenia: version III – the final common pathway. Schizophr Bull
2009; 35: 549–62.
Jacobsen, LK, D'Souza, DC, Mencl, WE, Pugh, KR, Skudlarski, P, Krystal, JH.
Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry
2004; 55: 850–8.
Zhang, XY, Chen da, C, Xiu, MH, Haile, CN, Sun, H, Lu, L, et al.
Cigarette smoking and cognitive function in chinese male schizophrenia: a case–control study. PLoS ONE
2012; 7: e36563.
Strauss, E, Sherman, EMS, Spreen, O.
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (3rd edn). Oxford University Press, 2006.
Esterberg, ML, Jones, EM, Compton, MT, Walker, EF.
Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls. Schizophr Res
2007; 97: 6–13.
Yoshimasu, K, Kiyohara, C.
Genetic influences on smoking behavior and nicotine dependence: a review. J Epidemiol
2003; 13: 183–92.
Wing, VC, Wass, CE, Soh, DW, George, TP.
A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Ann N Y Acad Sci
2011; 1248: 89–106.
Brunzell, DH, McIntosh, JM.
Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia. Neuropsychopharmacology
2011; 37: 1134–43.